CDKN2A and breast carcinoma: As the Figure 13A shows, the alteration of CDKN2A implies malignant type (TNBC) of breast cancer, while the unalteration of CDKN2A implies mild subtype (LumA) of breast cancer (p= 5.44e-5, Figure 13A).